跳至主要内容
临床试验/ACTRN12622001278729
ACTRN12622001278729招募中未知

Transcutaneous oxygen and Nasal High flow: a prospective, interventional, crossover, randomised, feasibility study investigating the effect of nasal high flow oxygen delivery on transcutaneous oxygen partial pressure in healthy adults

Fisher & Paykel Healthcare0 个研究点目标入组 6 人开始时间: 2022年9月29日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • 1. Willing and able to provide written informed consent
  • 2. 18 to 40 years of age, inclusive

排除标准

  • 1. Participants where continuous positive airway pressure and nasal high flow are contraindicated (e.g. nasal congestion, currently has or has history of epistaxis, pneumothorax, bullous lung disease, craniofacial trauma, airway foreign body).
  • 2. Known active use of tobacco, vapes, or other inhaled substances.
  • 3. BMI > 35 kg/m2
  • 4. Known fragile skin and/or adhesive allergy
  • 5. Other underlying medical condition that will be unfavourable for the administration of nasal high flow therapy or may impair compliance with study conduct.

研究者

相似试验